Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients
FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product. 		FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
PHOSPHORIC ACID TOPICAL; EMULSION, CREAM
PHOSPHORIC ACID TOPICAL; LOTION
PHOSPHORIC ACID TOPICAL; LOTION, AUGMENTED
PHOSPHORIC ACID TOPICAL; OINTMENT
PHOSPHORIC ACID TOPICAL; SOLUTION
PHOSPHORIC ACID TOPICAL; SPONGE
PHOSPHORIC ACID VAGINAL; EMULSION, CREAM
PINE NEEDLE OIL TOPICAL; LOTION
PINEAPPLE ORAL; CONCENTRATE
PIPERAZINE ORAL; TABLET
PIPERAZINE HEXAHYDRATE VAGINAL; EMULSION, CREAM
PLACEBO ORAL; TABLET
PLASTIBASE-50W DENTAL; PASTE
PLASTIBASE-50W TOPICAL; OINTMENT
PLUSWEET SUBLINGUAL; TABLET
POLACRILIN ORAL-21; TABLET
POLACRILIN ORAL-28; TABLET
POLACRILIN POTASSIUM ORAL; CAPSULE
POLACRILIN POTASSIUM ORAL; SUSPENSION, LIQUID
POLACRILIN POTASSIUM ORAL; TABLET
POLACRILIN POTASSIUM ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED
POLACRILIN POTASSIUM ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
POLACRILIN POTASSIUM ORAL; TABLET, COATED
POLACRILIN POTASSIUM ORAL; TABLET, FILM COATED
POLACRILIN POTASSIUM ORAL; TABLET, SUSTAINED ACTION
POLACRILIN POTASSIUM ORAL-21; TABLET
POLACRILIN POTASSIUM ORAL-28; TABLET
POLISH WAX 7625 P 100 ORAL; TABLET
POLISHING SOLUTION IM-182 ORAL; TABLET
POLISTIREX OPHTHALMIC; SUSPENSION
POLISTIREX OPHTHALMIC; SUSPENSION, DROPS
POLOXAMER 124 ORAL; SUSPENSION
POLOXAMER 181 TOPICAL; LOTION
POLOXAMER 182D TOPICAL; GEL
POLOXAMER 188 INTRAVENOUS; INJECTION
POLOXAMER 188 INTRAVENOUS; POWDER, FOR INJECTION SOLUTION
POLOXAMER 188 OPHTHALMIC; SOLUTION
POLOXAMER 188 OPHTHALMIC; SOLUTION, DROPS
POLOXAMER 188 ORAL; CONCENTRATE
POLOXAMER 188 ORAL; GRANULE
POLOXAMER 188 ORAL; POWDER, FOR ORAL SUSPENSION
POLOXAMER 188 ORAL; POWDER, FOR SOLUTION
POLOXAMER 188 ORAL; SOLUTION
POLOXAMER 188 ORAL; SUSPENSION
POLOXAMER 188 ORAL; SYRUP
POLOXAMER 188 ORAL; TABLET
POLOXAMER 188 ORAL; TABLET, CONTROLLED RELEASE
POLOXAMER 188 ORAL; TABLET, EXTENDED RELEASE
POLOXAMER 188 SUBCUTANEOUS; INJECTION
POLOXAMER 188 SUBCUTANEOUS; SOLUTION, INJECTION
POLOXAMER 188 TOPICAL; EMULSION, CREAM
POLOXAMER 188 TOPICAL; GEL
POLOXAMER 237 TOPICAL; SPONGE
POLOXAMER 331 ORAL; POWDER, FOR SOLUTION
POLOXAMER 331 ORAL; POWDER, FOR SUSPENSION
POLOXAMER 331 ORAL; SUSPENSION
POLOXAMER 338 ORAL; CAPSULE, ENTERIC COATED PELLETS
POLOXAMER 407 OPHTHALMIC; SOLUTION
POLOXAMER 407 OPHTHALMIC; SOLUTION, DROPS
POLOXAMER 407 ORAL; POWDER, FOR ORAL SUSPENSION
POLOXAMER 407 ORAL; SOLUTION
POLOXAMER 407 ORAL; TABLET, FILM COATED
POLOXAMER 407 TOPICAL; EMULSION, CREAM
POLOXAMER 407 TOPICAL; GEL
POLOXAMER 407 TOPICAL; SOLUTION
POLY(BIS(P-CARBOXYPHENOXY)PROPANE ANHYDRIDE):SEBACIC ACID IMPLANTATION; WAFER
POLY(DIMETHYLSILOXANE/METHYLVINYLSILOXANE/METHYLHYDROGENSILOXANE) DIMETHYLVINYL OR DIMETHYLHYDROXY OR TRIMETHYL ENDBLOCKED VAGINAL; DRUG DELIVERY SYSTEM
POLYBUTENE TRANSDERMAL; PATCH, CONTROLLED RELEASE
POLYCARBOPHIL BUCCAL; TABLET
POLYCARBOPHIL TOPICAL; PATCH
POLYCARBOPHIL VAGINAL; GEL
POLYCARBOPHIL, CALCIUM ORAL; TROCHE
POLYDEXTROSE ORAL; TABLET
POLYDEXTROSE ORAL; TABLET, COATED
POLYDEXTROSE ORAL; TABLET, CONTROLLED RELEASE
POLYDEXTROSE ORAL; TABLET, FILM COATED
POLYDEXTROSE ORAL; TABLET, SUSTAINED ACTION
POLYDEXTROSE K ORAL; TABLET, FILM COATED
POLYESTER BUCCAL; PATCH, CONTROLLED RELEASE
POLYESTER TRANSDERMAL; FILM, CONTROLLED RELEASE
POLYESTER TRANSDERMAL; PATCH, CONTROLLED RELEASE
POLYESTER VAGINAL; INSERT, EXTENDED RELEASE
POLYESTER - FLUORO CHEMICAL RELEASING AGENT TRANSDERMAL; FILM, CONTROLLED RELEASE
POLYESTER FLUOROCARBON DIACRYLATE TRANSDERMAL; FILM, CONTROLLED RELEASE
POLYESTER POLYAMINE COPOLYMER TRANSDERMAL; FILM, CONTROLLED RELEASE
POLYESTER RAYON BUCCAL; PATCH, CONTROLLED RELEASE
POLYETHYLENE BUCCAL/SUBLINGUAL; TABLET
POLYETHYLENE DENTAL; PASTE
POLYETHYLENE INTRAUTERINE; INTRAUTERINE DEVICE
POLYETHYLENE OPHTHALMIC; OINTMENT
POLYETHYLENE ORAL; CAPSULE
POLYETHYLENE ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
POLYETHYLENE ORAL; TABLET, SUSTAINED ACTION
POLYETHYLENE TOPICAL; GEL
POLYETHYLENE TOPICAL; OINTMENT
POLYETHYLENE TOPICAL; PASTE
POLYETHYLENE TOPICAL; TAPE
POLYETHYLENE TRANSDERMAL; FILM, CONTROLLED RELEASE
POLYETHYLENE VAGINAL; SUPPOSITORY
POLYETHYLENE GLYCOL 1000 ORAL; CONCENTRATE

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link